Ultimate Real-World Data Showdown

Run Time

10 minutes
rwd-after-dark-logo

This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance discussing how real-world data (RWD), EMR data, and AI are transforming pharma decision-making and patient care. Through a game-show-style conversation, they explore how integrated datasets and unstructured clinical data help generate real-world evidence, improve patient identification, accelerate therapies to market, and deliver meaningful impact beyond traditional ROI. The episode also highlights the future of predictive analytics and large language models, which could enable earlier disease detection and fundamentally change how patients receive treatment.

Frequently asked questions

What is real-world data (RWD)?
Real-world data (RWD) includes healthcare information collected outside of traditional clinical trials, such as claims data, EMR data, lab results, and physician notes. It helps life sciences organizations better understand patient journeys, treatment decisions, and outcomes.
How has RWD evolved in recent years?
RWD has evolved from primarily claims-based datasets to more integrated ecosystems that include EMR, lab, and unstructured clinical data. This shift enables deeper clinical insights and more meaningful evidence generation.
What is EMR data and why is it important?
Electronic medical record (EMR) data captures detailed clinical information about patients, including physician notes, symptoms, treatment decisions, and disease progression. It provides context that traditional claims data alone cannot offer.
What is the value of unstructured clinical data?
Unstructured data, such as physician notes and clinical narratives, helps reveal why treatment decisions are made, how patients are responding to therapy, and what factors influence outcomes.

Dive into the series

Real-world data can be complex, but it doesn’t have to be. Real-World Data After Dark blends deep insights with light late-night talk show banter. Our experts unpack complex challenges, spark new ideas, and show how real-world data shapes pharma strategy and drives better patient outcomes—with a twist.
Daniel-Chancellor
Dan Chancellor
VP, Thought Leadership, Norstella
madeline-naylor-headshot
Dr. Madeline Naylor, DHSc, MMS, CCRP
Chief Clinician, Norstella
lance-wolkenbrod-headshot
Lance Wolkenbrod
Senior Principal, Real-World Data Solutions, Norstella

Norstella Brands